睾酮治疗与男性性功能:T4DM(糖尿病睾酮治疗)试验的二次分析
这项T4DM试验二次分析纳入1007名50-74岁2型糖尿病高危或新诊断男性,每3个月肌注十一酸睾酮1000 mg或安慰剂共2年并联合生活方式干预。睾酮改善全部5个IIEF-15域评分,对性欲和性高潮功能作用较强,尤其老年男性;腰围和抑郁评分下降独立改善性功能。
要点
- 睾酮治疗改善全部5个IIEF-15域评分,对性欲和性高潮功能作用较强,老年男性更明显。
- 勃起功能和性欲出现临床显著改善者分别占3%和10%,且与基线功能呈负相关。
- 腰围下降与勃起功能改善相关,抑郁评分下降与性功能改善相关,均独立于治疗。
核心结论
- 睾酮治疗增强性欲,并在较小程度上改善勃起功能,尤其在老年男性及腰围较大或抑郁症状较多者中。
- 腰围减少和抑郁改善可独立改善性功能。
研究设计与样本
- T4DM试验的二次分析,该试验为双盲、安慰剂对照试验,在6个澳大利亚中心开展。
- 研究对象为50至74岁、经口服葡萄糖耐量试验判定为2型糖尿病高危或新诊断的男性。
- 干预为每3个月肌内注射十一酸睾酮1000 mg或安慰剂,共2年,同时参加社区生活方式项目。
- 1007名参与者中792名(79%)具有完整的IIEF-15数据。
主要发现
- 基线各域评分与年龄和腰围呈负相关,但与血清睾酮或雌二醇水平无关。
- 睾酮治疗改善全部5个IIEF-15域评分,对老年男性的性欲和性高潮功能作用更强,对抑郁评分较高男性的性欲作用更强。
- 睾酮对抑郁无影响。
- 独立于治疗,腰围减少与勃起功能改善相关,抑郁评分下降与性功能改善相关。
- 勃起功能和性欲出现临床显著改善者分别占3%和10%,且与基线功能呈负相关;临床显著改善在较年轻和较年长男性中分别更明显(对应勃起功能和性欲)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The combined effects of testosterone treatment and lifestyle intervention on sexual function in men at high risk of type 2 diabetes are unclear. OBJECTIVE: To assess the effect of testosterone treatment with a lifestyle intervention in men aged 50 to 74 years at high risk of, or newly diagnosed with, type 2 diabetes (via oral glucose tolerance test). DESIGN: A secondary analysis of the Testosterone for the Prevention of Type 2 Diabetes trial, a double-blind, placebo-controlled trial conducted across 6 Australian centers. INTERVENTIONS: Intramuscular testosterone undecanoate (1000 mg) or placebo, 3 monthly for 2 years alongside a community-based lifestyle program. MAIN OUTCOMES: Sexual function measured using the International Index of Erectile Function (IIEF)-15 questionnaire. RESULTS: Of 1007 participants, 792 (79%) had complete International Index of Erectile Function-15 data. Baseline domain scores were inversely related to age and waist circumference, but unrelated to serum testosterone or estradiol levels. Testosterone treatment improved all 5 International Index of Erectile Function-15 domain scores, with stronger effects on sexual desire and orgasmic function in older men, and sexual desire in men with higher depression scores. Testosterone had no impact on depression. Independent of treatment, reductions in waist circumference were associated with improved erectile function, and reductions in depression scores correlated with better sexual function. Clinically significant improvement in erectile function and sexual desire occurred in 3% and 10% of men, respectively, and was inversely related to baseline function. Clinically significant improvement improvements in erectile function and sexual desire were greater in younger and older men respectively. CONCLUSION: Testosterone treatment enhanced sexual desire and, to a lesser extent, erectile function, particularly in older men and those with higher waist circumference or depressive symptoms. Reduced waist circumference and depression independently improved sexual function.
引用
- Wittert GA, Robledo KP, Handelsman DJ, et al. Testosterone Treatment and Sexual Function in Men: Secondary Analysis of the T4DM (Testosterone for Diabetes) Trial. J Clin Endocrinol Metab. 2025. PMID: 39928571. doi:10.1210/clinem/dgaf060
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。